Clinical Update on the Evolving Role of B-Cell Targeting Therapies to Improve Outcomes in Patients with Generalized Myasthenia Gravis
Beyond Symptom Control: Targeting BAFF/APRIL Pathways in Generalized Myasthenia Gravis
AANEM 2025: Conference Review and Analysis for New Data on Emerging BAFF/APRIL Inhibitors for the Management of Patients with Generalized Myasthenia Gravis
